University Hospitals Seidman Cancer Center
In research, University Hospitals Seidman Cancer Center stands highest in Medicine (#3,174 of 10,443 worldwide) and Health Sciences (#4,398 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Oncology and Pulmonary and Respiratory Medicine — Oncology is 17.2× its share of world research.
- World rank, 2022–2025
- #8,111 of 28,054 · #11,631 all time
- Rank in United States
- #1,082 of 4,192
- Research works
- 761 ▲ 33% vs 2013–17
- Citations
- 18k 23.2 per fractional work
- Top-10% rate
- 18.0% record average 16.5%
- Open access
- 41% world 28%
What is University Hospitals Seidman Cancer Center known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #3,174 of 10,443 | 18.3% | 201 | #3694 | |
| Health SciencesDomain | #4,398 of 11,982 | 18.1% | 206 | #4966 |
Each strip is that field’s whole ranked pool, with the notch where University Hospitals Seidman Cancer Center sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
What does University Hospitals Seidman Cancer Center specialise in?
Where its research is concentrated relative to its size: Oncology takes 17.2× the share of its output that it takes of world research.
- OncologySubfield · 53.0 works17×
- Pulmonary and Respiratory MedicineSubfield · 41.6 works9.9×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 3.8×. Every wedge is a field page.
- Medicine 3.8×
- Immunology and Microbiology 2.7×
- Biochemistry, Genetics and Molecular Biology 2.1×
- Economics, Econometrics and Finance 1.4×
- Physics and Astronomy 1.0×
- Pharmacology, Toxicology and Pharmaceutics 0.8×
- Health Professions 0.6×
- Neuroscience 0.3×
- Psychology 0.2×
- Mathematics 0.2×
- Chemistry 0.2×
- Nursing 0.2×
- Dentistry 0.1×
- Materials Science 0.1×
- Social Sciences 0.1×
- Engineering 0.1×
- Computer Science 0.1×
- Decision Sciences 0.1×
- Environmental Science 0.0×
- Agricultural and Biological Sciences 0.0×
- Arts and Humanities 0.0×
- Business, Management and Accounting 0.0×
Who are the top researchers at University Hospitals Seidman Cancer Center?
Ranked on the composite score, Lisa R. Rogers, Rodney J. Ellis and Bryan Traughber lead among researchers whose main affiliation is University Hospitals Seidman Cancer Center.
- 1 Lisa R. Rogers United States · #149,652 worldwide 136 citations · 45 works
- 2 Rodney J. Ellis United States · #218,981 worldwide 78 citations · 36 works
- 3 Bryan Traughber United States · #863,719 worldwide 23 citations · 22 works
- 4 Sakti Chakrabarti United States · #1,094,192 worldwide 14 citations · 24 works
- 5 Pedro C. Barata United States · #1,102,717 worldwide 43 citations · 60 works
- 6 Benjamin Tomlinson United States · #1,266,720 worldwide 16 citations · 19 works
Which keywords describe research at University Hospitals Seidman Cancer Center?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Immunotherapy, Chemotherapy, Clinical Trials, Radiotherapy, Prognostic Factors, Targeted Therapy, Tumor Microenvironment and Genetic Mutations.
- Genetic Variants
- Radiation Therapy
- Biopsy
- PET Imaging
- Screening
- Cancer Incidence
- Immune Checkpoint Blockade
- Surgical Management
- Dosimetry
- Molecular Biology
- Androgen Receptor
- Hormone Therapy
- Molecular Characterization
- Clinical Practice Guidelines
- Cancer
- Biomarkers
- Genetic Mutations
- Targeted Therapy
- Radiotherapy
- Chemotherapy
- Immunotherapy
- Clinical Trials
- Prognostic Factors
- Tumor Microenvironment
- Prostate Cancer
- Genomic Profiling
- Neoadjuvant Therapy
- Quality of Life
- Survival Analysis
- Clinical Guidelines
- Metastatic Prostate Cancer
- Cancer Therapy
- Metastasis
- Cancer Treatment
- PD-1 and PD-L1
- Proteasome Inhibitors
- Genomic Instability
- Staging System
- Population-Based Study
- Cancer Immunotherapy
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Immunotherapy39▲ 20×16 topics
- Chemotherapy33▲ 17×23 topics
- Clinical Trials22▲ 12×11 topics
- Radiotherapy22▲ 21×11 topics
- Prognostic Factors21▲ 17×12 topics
- Targeted Therapy18▲ 30×5 topics
- Tumor Microenvironment17▲ 14×8 topics
- Genetic Mutations17▲ 14×9 topics
- Prostate Cancer15▲ 43×4 topics
- Biomarkers15▲ 7.9×11 topics
- Genomic Profiling14▲ 49×2 topics
- Cancer13▲ 3.5×36 topics
- Neoadjuvant Therapy13▲ 20×5 topics
- Clinical Practice Guidelines12▲ 8.1×9 topics
- Quality of Life12▲ 3.1×18 topics
- Molecular Characterization11▲ 23×4 topics
- Survival Analysis11▲ 14×6 topics
- Hormone Therapy9▲ 42×2 topics
- Clinical Guidelines9▲ 12×6 topics
- Androgen Receptor9▲ 44×2 topics
- Metastatic Prostate Cancer9▲ 79×1 topic
- Molecular Biology9▲ 78×1 topic
- Cancer Therapy8▲ 5.5×14 topics
- Dosimetry8▲ 44×2 topics
- Metastasis8▲ 9.2×10 topics
- Surgical Management8▲ 7.2×8 topics
- Cancer Treatment8▲ 12×6 topics
- Immune Checkpoint Blockade8▲ 26×1 topic
- PD-1 and PD-L18▲ 26×1 topic
- Cancer Incidence8▲ 21×4 topics
- Proteasome Inhibitors7▲ 37×2 topics
- Screening7▲ 28×2 topics
- Genomic Instability7▲ 23×3 topics
- PET Imaging7▲ 15×4 topics
- Staging System7▲ 42×2 topics
- Biopsy7▲ 41×2 topics
- Population-Based Study7▲ 38×2 topics
- Radiation Therapy7▲ 19×4 topics
- Cancer Immunotherapy7▲ 16×3 topics
- Genetic Variants7▲ 14×5 topics
Which research topics does University Hospitals Seidman Cancer Center publish most on?
By volume in 2022–2025: Prostate Cancer Treatment and Research, Cancer Immunotherapy and Biomarkers, Prostate Cancer Diagnosis and Treatment and Cancer Genomics and Diagnostics.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Prostate Cancer Treatment and Research Pulmonary and Respiratory Medicine 9 works
- 2 Cancer Immunotherapy and Biomarkers Oncology 8 works
- 3 Prostate Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 6 works
- 4 Cancer Genomics and Diagnostics Cancer Research 6 works
- 5 Advanced Radiotherapy Techniques Radiation 6 works
- 6 Multiple Myeloma Research and Treatments Hematology 6 works
- 7 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 5 works
- 8 Economic and Financial Impacts of Cancer Economics and Econometrics 5 works
- 9 CAR-T cell therapy research Oncology 5 works
- 10 Lung Cancer Research Studies Oncology 5 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has University Hospitals Seidman Cancer Center's research output changed?
Output in 2018–2022 was 33% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Cleveland
- Case Western Reserve University
- Cleveland Clinic
- Glenn Research Center
- Cleveland State University
- University Hospitals of Cleveland
- University School
- Cleveland Clinic Lerner College of Medicine
- Cleveland Foundation
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.